Back to Results
Zheng "Frank" Zhou, MD, PhD
Accepting New Patients
Hematologist, Stem Cell Transplant Physician, Associate Director, Adult Stem Cell Transplantation and Cellular Therapy
Department + Services
Medicine, Hematology Oncology, Stem Cell Transplantation and Cellular Therapy
Clinical Focus Areas
Stem Cell Transplantation, Leukemias, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Hematological Malignancies
Research Focus Areas
Clinical Trials, Pharmacoepidemiology, Survival Analysis, Predictive Models, Medical Database based research
Seeing Patients In
Tufts Medical Center
800 Washington St.
South Building, Floor 8
Boston, MA 02111
Phone #: 617-636-6227
Fax #: 617-636-8538
Northwestern Medicine Jameson Research Prize for Outstanding Research Contributions (2014)
ECOG/ACRIN 12th Annual ECOG/Sanofi-Aventis Oncology Young Investigator Symposium Award (2012)
National Institute of Health (T32 CA 79447-15) Clinical Fellow Research Training Grant (2012-2014)
ASCO-AACR 2013 Vail Clinical Trial Workshop Selected Attendee and Protocol
Illinois Medical Oncology Society Annual Fellow Research Award.
Zhou Z, Nath R, Cerny J, Wang H-L, Saber W, et al. (2020) Reduced Intensity Conditioning for Acute Myeloid Leukemia using Melphalan versus Busulfan based Regimens – A CIBMTR Report. Blood Advances 4(13): 3180–90.
Zhou Z, Rademaker A, Gordon LI, LaCasce AS, Crosby-Thompson AL, et al. (2016) High body mass index in elderly DLBCL patients treated with rituximab containing therapy compensates for negative impact of male sex. JNCCN. 14:1274-81
Zhou Z, Gao J, Popovic R, Wolniak K, Parimi V, Winter, JN, Licht JD, et al. (2015) Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma (DLBCL) independent of cell of origin and EZH2 codon 641 mutation. Leukemia and Lymphoma. 56(10):2895-901.
Zhou Z, Sehn L, Rademaker A, Gordon LI, LaCasce AS, Crosby-Thompson AL, Winter JN et al. (2014) An enhanced international prognostic index (NCCN-IPI) for patients with diffuse large B cell lymphoma treated in the rituximab era. Blood 123(6): 837-42
Zhou Z, Peretz Y, Chang Y, Li X, Miao DS, and Prud'homme GJ (2003) Intramuscular Gene Transfer of Soluble B7-1/IgG1 Fusion cDNA Induces Potent Antitumor Immunity as an Adjuvant for DNA Vaccination. Cancer Gene Therapy 10(6): 491-9
Zhou Z, and Lam P (2007). Discussion on Use of Propensity Score in Non-randomized Clinical Studies in Medical Device. Journal of Biopharmaceutical Statistics 17(1):25-7
Zhou Z, Rahme E, Abrahamowicz M, Pilote L (2005). Survival Bias Associated with Time-to-Treatment Initiation in Drug Effectiveness Evaluation: A Comparison of Methods. American Journal of Epidemiology 162(10):1016-23
American Society of Hematology (ASH)
American Society of Transplantation and Cellular Therapy (ASTCT)
Foundation for the Accreditation of Cellular Therapy (FACT)
American College of Physicians (ACP)